Detalles de la búsqueda
1.
Neoadjuvant relatlimab and nivolumab in resectable melanoma.
Nature;
611(7934): 155-160, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36289334
2.
Author Correction: Neoadjuvant relatlimab and nivolumab in resectable melanoma.
Nature;
615(7953): E23, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36894629
3.
Comparative safety and effectiveness of TNF inhibitors, IL6 inhibitors and methotrexate for the treatment of immune checkpoint inhibitor-associated arthritis.
Ann Rheum Dis;
82(7): 920-926, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37019614
4.
Imaging features of immune checkpoint inhibitor-related nephritis with clinical correlation: a retrospective series of biopsy-proven cases.
Eur Radiol;
33(3): 2227-2238, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36255488
5.
Cutaneous adverse events in 155 patients with metastatic melanoma consecutively treated with anti-CTLA4 and anti-PD1 combination immunotherapy: Incidence, management, and clinical benefit.
Cancer;
128(5): 975-983, 2022 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34724197
6.
PIVOT-12: a phase III study of adjuvant bempegaldesleukin plus nivolumab in resected stage III/IV melanoma at high risk for recurrence.
Future Oncol;
18(8): 903-913, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35073733
7.
A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant.
Kidney Int;
100(1): 196-205, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33359528
8.
Genetic determinants of immune-related adverse events in patients with melanoma receiving immune checkpoint inhibitors.
Cancer Immunol Immunother;
70(7): 1939-1949, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33409738
9.
Cytokines in the Treatment of Melanoma.
Curr Oncol Rep;
23(7): 83, 2021 05 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34003395
10.
Intracranial antitumor activity with encorafenib plus binimetinib in patients with melanoma brain metastases: A case series.
Cancer;
126(3): 523-530, 2020 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31658370
11.
TERT amplification but not activation of canonical Wnt/ß-catenin pathway is involved in acral lentiginous melanoma progression to metastasis.
Mod Pathol;
33(10): 2067-2074, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32404956
12.
Bempegaldesleukin plus nivolumab in untreated, unresectable or metastatic melanoma: Phase III PIVOT IO 001 study design.
Future Oncol;
16(28): 2165-2175, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32723187
13.
Pegilodecakin combined with pembrolizumab or nivolumab for patients with advanced solid tumours (IVY): a multicentre, multicohort, open-label, phase 1b trial.
Lancet Oncol;
20(11): 1544-1555, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31563517
14.
Incidence, patterns of progression, and outcomes of preexisting and newly discovered brain metastases during treatment with anti-PD-1 in patients with metastatic melanoma.
Cancer;
125(23): 4193-4202, 2019 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31398264
15.
Immune checkpoint inhibitor-induced colitis as a predictor of survival in metastatic melanoma.
Cancer Immunol Immunother;
68(4): 553-561, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30666357
16.
Gene expression profiling of lichenoid dermatitis immune-related adverse event from immune checkpoint inhibitors reveals increased CD14+ and CD16+ monocytes driving an innate immune response.
J Cutan Pathol;
46(9): 627-636, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-30883858
17.
Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial.
Lancet Oncol;
19(2): 181-193, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29361468
18.
Calcinosis cutis dermatologic toxicity associated with fibroblast growth factor receptor inhibitor for the treatment of Wilms tumor.
J Cutan Pathol;
45(10): 786-790, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-30021048
19.
Suprabasal acantholytic dermatologic toxicities associated checkpoint inhibitor therapy: A spectrum of immune reactions from paraneoplastic pemphigus-like to Grover-like lesions.
J Cutan Pathol;
45(10): 764-773, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-29943453
20.
Metastatic Melanoma of the Optic Nerve Sheath.
Neuroophthalmology;
42(3): 187-190, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29796055